UniFirst No. 9 Chevrolet Set for June 8 Race at Michigan International Speedway
The freshly designed UniFirst No. 9 Chevrolet exudes energy with its bold green and gray tones, sleek racing stripes, and the iconic "U-Mark" symbolizing UniFirst's commitment to exceptional service.
"The UniFirst No. 9 is back, and we're fired up to see Chase go for a win in Michigan," said David Katz, Executive Vice President of Sales and Marketing at UniFirst. "NASCAR fans bring unmatched energy, and we're proud to be part of the excitement on race day."
The Michigan race is one of five appearances for the UniFirst No. 9 Chevrolet during the 2025 NASCAR Cup Series season. Fans can also look forward to seeing the UniFirst No. 9 on these final two upcoming dates:
August 16 at Richmond Raceway
October 5 at Charlotte Motor Speedway ROVAL
"I'm looking forward to getting the UniFirst Chevy on track at Michigan," said Elliott, who has 10 top-10 finishes in 14 starts at the 2-mile oval. "It's a fast track and one that I enjoy going to. Last year, we were able to lead some laps but didn't quite get the finish we wanted. Ready to see what we can accomplish this weekend with the UniFirst colors on board."
The partnership between UniFirst and Hendrick Motorsports reaches a milestone in 2025, marking 10 years of collaboration. This year also marks the sixth season UniFirst has sponsored Chase Elliott and the No. 9 team. UniFirst is the Official Workwear Provider of Hendrick Motorsports, supplying work clothing and uniforms to the team, as well as to its sister company, Hendrick Automotive Group. For more information on UniFirst, visit UniFirst.com.
About UniFirst
Headquartered in Wilmington, Mass., UniFirst Corporation (NYSE: UNF) is a North American leader in the supply and servicing of uniform and workwear programs, facility service products, as well as first aid and safety supplies and services. Together with its subsidiaries, the company also manages specialized garment programs for the cleanroom and nuclear industries. In addition to partnering with leading brands, UniFirst manufactures its own branded workwear, protective clothing, and floorcare products at its three company-owned ISO-9001-certified manufacturing facilities. With more than 270 service locations, over 300,000 customer locations, and 16,000-plus employee Team Partners, the company outfits more than 2 million workers every day. For additional information, contact UniFirst at 888.296.2740 or visit UniFirst.com. Follow UniFirst on Social Media: LinkedIn, Facebook, X, YouTube, Instagram.
About Hendrick Motorsports:
Founded by Rick Hendrick in 1984, Hendrick Motorsports is the winningest team in NASCAR Cup Series history. At the sport's premier level, the organization holds the all-time records in every major statistical category, including championships (14), points-paying race victories (316) and laps led (more than 83,000). It has earned at least one race win in a record 41 different seasons, including an active streak of 40 in a row (1986-2025). The team fields four full-time Chevrolet entries in the NASCAR Cup Series with drivers Alex Bowman, William Byron, Chase Elliott and Kyle Larson. Headquartered on more than 150 acres in Concord, North Carolina, Hendrick Motorsports employs approximately 600 people. For more information, please visit HendrickMotorsports.com or interact on Facebook, Instagram, TikTok and X.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Canada News.Net
12 hours ago
- Canada News.Net
Birkenstock, Bugaboo, Coach thrive as rich Americans absorb hikes
LONDON, U.K.: For now, America's wealthier consumers appear unfazed by price increases on high-end products, from Birkenstock sandals to Bugaboo strollers, even as tariffs and economic uncertainty push brands to raise prices. German footwear brand Birkenstock has seen "tremendously strong" demand since introducing higher prices on July 1 to offset U.S. import tariffs, CEO Oliver Reichert told analysts this week. "We saw no pushback or cancellations," he said. The resilience mirrors trends across several premium brands. Bugaboo, the Dutch maker of strollers, high chairs, and playpens retailing for more than US$1,000, raised prices by $50 to $300 in May. "In general, we did not see any pushback," said Jeanelle Teves, Bugaboo's chief commercial officer for North America, noting retailers were "open and accepting" of the changes. Coach handbags have also remained popular, with parent company Tapestry reporting 4.6 million new North American customers this year, many from Gen Z and millennial demographics. CEO Joanne Kuvoiserat said the brand expects to maintain profit margins despite tariff pressures. Ralph Lauren likewise raised its annual revenue forecast as shoppers snapped up items like its $398 Polo Bear sweaters. However, CEO Patrice Louvet cautioned that price sensitivity in the second half remains a key unknown. Bank of America data supports the picture of steady luxury spending. The bank reported that middle—and upper-income cardholders spent more in July than a year earlier, even as spending by lower-income customers stayed flat. The bank noted that lower-income households account for only 15 percent of U.S. consumer spending, meaning overall demand could remain strong if higher-income spending holds up. However, some signs of caution are emerging. Procter & Gamble, maker of Tide detergent, noted that even wealthier consumers are becoming more selective in their purchases. Bugaboo manufactures in China and sells through retailers including Target, Nordstrom, and Bloomingdale's, as well as smaller independent stores. Coach's popular Tabby shoulder bag sells for $350, while Ralph Lauren's luxury apparel continues to command high prices. As brands watch the second half of the year unfold, the big question remains whether affluent shoppers will keep absorbing price hikes or begin to pull back in the face of a "broader pricing environment," Louvet said.
Global News
12 hours ago
- Global News
She's Got Next: Founders rally in Vancouver behind historic firsts in women's sports
Rogers Arena was host to a first on Friday night: the WNBA's inaugural regular-season game in Vancouver. Before tip-off, inside a private pre-game gathering, She's Got Next founders Julie Smulders and Jill Tracy brought together a powerhouse group of athletes, executives and community leaders to underline a message – Canada is entering a new era for women's sports, and it's time to show up. Smulders, a UBC Thunderbirds alumna who played professional basketball overseas, said the idea for She's Got Next began last year after she and Tracy left a sold-out NCAA women's Final Four and compared it to the Canada West championships in B.C., which drew just 500 fans. 'We thought, 'We can do something in Canada. Let's elevate women's sports. Let's bring a community of women together,' Smulders said. The private event drew some of the most influential figures in Canadian and North American sport: Toronto Tempo president Teresa Resch and general manager Monica Wright Rogers, NBA Canada communications director Ashton Lawrence, PWHL Vancouver general manager Cara Morey and director of business operations Tania Richards, and five-time Olympian and Canadian Olympic Committee president Charmaine Crooks. Story continues below advertisement 5:57 WNBA players call for pay equity Tempo also used the evening to announce that when their inaugural WNBA season tips off next year, two of their regular-season games will be played in B.C., marking another historic milestone for Canadian women's basketball. Instead of hosting galas, She's Got Next has built its brand around what Smulders calls 'games over galas.' The group organizes dedicated fan sections at women's sporting events, including Section 107 at PWHL Vancouver home games. Get daily National news Get the day's top news, political, economic, and current affairs headlines, delivered to your inbox once a day. Sign up for daily National newsletter Sign Up By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy That means when members join the organization, they don't just attend events—they show up in the stands together. 'It's about modelling behaviour,' Tracy said. 'Men have done it for decades—grabbing friends and going to games. We're making that the norm for women's sports.' This season also marks the arrival of PWHL Vancouver, the province's first professional women's hockey franchise. The league has already drawn record-setting attendance in Toronto, Ottawa and Montreal, and now Vancouver fans have a team of their own. Story continues below advertisement 23:49 WNBA in Canada: Teresa Resch hopes Toronto Tempo will 'inspire an entire new generation' Smulders and Tracy said they were emotional seeing young girls in jerseys at PWHL games earlier this year. 'There were no dry eyes in our group when the women took the ice and heard the national anthem,' Tracy recalled. 'We hadn't seen that before.' The fight for visibility in women's sports has been ongoing for a long time. For decades, women were excluded outright: in the U.K., women's soccer was banned for 50 years. In North America, women were often dismissed as 'unable' or 'unfit' to play. 'That mindset doesn't disappear overnight,' Smulders said. In Canada, progress has accelerated in recent years. Christine Sinclair became the world's all-time leading international goal scorer, cementing women's soccer as a national passion. Marie-Philip Poulin's overtime heroics turned her into 'Captain Clutch,' rewriting hockey history. Story continues below advertisement And now, Canadian broadcasters are carrying more women's games—including, for the first time this year, all Indiana Fever WNBA games featuring star rookie Caitlin Clark. 'If you don't see it, you don't believe it's possible,' Smulders said. 'Now kids across Canada are seeing it.' 1:57 'To be brave, and to be bold': WNBA empowering next generation Smulders remembered her UBC days when the women's basketball team was fed Subway while the men's team got steak dinners. 'We were grateful just to get anything,' she said. Today's generation isn't settling. 'They want jerseys in their size. They want visibility. They want equality,' Tracy said. 'To them, women are just athletes. Period.' For Smulders and Tracy, the message to fans, institutions and media is clear: women's sports are not a novelty, they are the future. Story continues below advertisement Alongside fan sections and events, She's Got Next is launching scholarships for student-athletes, building career pipelines for women graduating from university sport, and continuing to host pre-game gatherings that unite athletes, executives, coaches, entrepreneurs and fans. The organization also has dedicated fan sections starting with Section 107 at every PWHL Vancouver game. The first WNBA game in Vancouver, the arrival of PWHL hockey in B.C., and the coming Northern Super League aren't just milestones; they're an invitation. The question now is whether Canadians will keep showing up, not just for history, but for what comes next. 'Come to games. Become members. Tell your friends,' Smulders urged. Tracy added: 'The bigger the community, the bigger our impact.'
Globe and Mail
13 hours ago
- Globe and Mail
1 Stock Down 40% This Year to Buy and Hold
Key Points Novo Nordisk's shares have been trending downward due to clinical setbacks and underwhelming results. However, the company has some potential catalysts on the way that could jolt its stock price. Novo Nordisk looks attractive given its lineup and pipeline, especially at current levels. 10 stocks we like better than Novo Nordisk › Novo Nordisk (NYSE: NVO) first earned U.S. approval for its now-famous weight management medicine Wegovy in June 2021. That marked the beginning of a strong run for the company on the stock market. However, the Denmark-based drugmaker has given up most of these gains over the past year; the stock is down by 40% since January alone. Despite its recent misfortunes, Novo Nordisk's shares could still deliver strong returns to patient investors. Here's why. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » NVO Total Return Level data by YCharts. The weight management opportunity Novo Nordisk primarily develops medicines for diabetes and, in recent years, weight management. Its stock has plunged over the past year because its financial results haven't been as impressive as the market had hoped. It also faced some clinical setbacks, while its biggest rival in its core markets, Eli Lilly, earned some important wins. However, there's more to the story. The market for anti-obesity medications could grow at an incredibly rapid rate. Some analysts estimate that it will be worth $150 billion by 2035, compared to $15 billion last year. Novo Nordisk still has one of the deepest pipelines in the industry. In fact, it's challenging to find a company other than Eli Lilly that has more promising products. Recently, Novo Nordisk expanded its pipeline through various licensing deals. Here's one more thing that recently broke its way: Eli Lilly's oral GLP-1 candidate, orforglipron, did not perform nearly as well as expected in a phase 3 study. This opens the door for Novo Nordisk to catch up to its longtime rival. The company's oral version of Wegovy is currently awaiting approval from regulators in the U.S. The oral version led to an average weight reduction of 13.6% in a phase 3 clinical trial, slightly higher than the 12.4% that orforglipron recently posted in its late-stage study. While it's always hard to compare across clinical trials, the data at the very least suggests that oral Wegovy is comparable to orforglipron -- but only the former drug is closing in on approval. Novo Nordisk also has yet another promising anti-obesity candidate in phase 3 studies, amycretin, which the Denmark-based pharmaceutical giant is testing in both subcutaneous and oral formulations. Why is the race to develop an oral weight loss option so important? Pills are easier and cheaper to manufacture, store, and transport. So, compared to injectable weight loss therapies, oral versions would allow drugmakers to produce them more cost-effectively and to expand the reach of weight loss therapies. On top of that, some patients are strongly averse to needles. Because the current leading weight management drugs are administered subcutaneously, an oral option would likely take a decent share of the market. Novo Nordisk is likely to be first to market. And the company could follow up that win with another oral product in amycretin. The price is right Let's go back to Novo Nordisk's recent and disappointing financial results. In the first half of the year, revenue rose by 16% year over year to 154.9 billion Danish kroner ($24.2 billion), while net profit came in at 55.5 billion DKK ($8.7 billion). Perhaps that's not quite what the market expected to see, but these are still excellent results for a pharmaceutical giant -- most drugmakers of that size would be happy to grow their revenue at high-single-digit or low-double-digit rates. Meanwhile, the stock appears reasonably valued, trading at 13 times forward earnings, compared to the healthcare industry 's average of 16.2. What's the verdict? Novo Nordisk looks attractive at current levels, given the company's strong pipeline in weight management and a lineup that continues to deliver consistent profits. Despite recent setbacks, the stock is well-positioned to deliver excellent results over the long term. Should you invest $1,000 in Novo Nordisk right now? Before you buy stock in Novo Nordisk, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Novo Nordisk wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $668,155!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,106,071!* Now, it's worth noting Stock Advisor's total average return is 1,070% — a market-crushing outperformance compared to 184% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 13, 2025
